PL EN


Preferences help
enabled [disable] Abstract
Number of results
2000 | 48 | 4 | 225-233
Article title

Differential effects of CD40 stimulation on normal and neoplastic cell growth

Title variants
Languages of publication
EN
Abstracts
EN
CD40 is a molecule in the tumor necrosis factor receptor/nerve growth factor receptor (TNFR/NGFR) family that is present on both normal and neoplastic B lineage cells. It is also expressed on carcinoma and melanoma cells and can be augmented with interferon gamma CD40 stimulation in normal Bcells has been demonstrated to promote normal B cell differentiation and growth in vitro. In contrast to these effects, CD40 stimulation by either anti-CD40 antibodies or a recombinant soluble CD40 ligand can inhibit the growth of human breast carcinomas and aggressive histology B lymphomas in vitro and in vivo. This is believed to occur by activation- -induced cell death (AICD) in which stimuli that promote the growth of normal cell types inhibit the growth of neoplastic counterparts. This occurs through the induction of apoptosis, necrosis and/or cell cycle arrest. Thus, CD40 stimulation may be of potential clinical use in the treatment of carcinomas and B cell lymphomas. This review shall provide an overview of the various effects of CD40 stimulation on both normal and neoplastic cell types.
Keywords
Contributors
author
author
author
author
References
Document Type
REVIEW
Publication order reference
J.L. Ziebold, NCI-FCRDC, Laboratory of Leukocyte Biology, Frederick, Maryland, USA
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-46a4b906-9381-3cc4-8568-2bf08132a819
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.